WO2007010305A3 - Surgical membrane - Google Patents

Surgical membrane Download PDF

Info

Publication number
WO2007010305A3
WO2007010305A3 PCT/GB2006/050209 GB2006050209W WO2007010305A3 WO 2007010305 A3 WO2007010305 A3 WO 2007010305A3 GB 2006050209 W GB2006050209 W GB 2006050209W WO 2007010305 A3 WO2007010305 A3 WO 2007010305A3
Authority
WO
WIPO (PCT)
Prior art keywords
membrane
gff
generate
enriched
methods
Prior art date
Application number
PCT/GB2006/050209
Other languages
French (fr)
Other versions
WO2007010305A2 (en
Inventor
Harminder Dua
Andrew Hopkinson
Original Assignee
Univ Nottingham
Harminder Dua
Andrew Hopkinson
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nottingham, Harminder Dua, Andrew Hopkinson filed Critical Univ Nottingham
Priority to GB0800732A priority Critical patent/GB2441939B/en
Priority to US11/995,579 priority patent/US20080193554A1/en
Publication of WO2007010305A2 publication Critical patent/WO2007010305A2/en
Publication of WO2007010305A3 publication Critical patent/WO2007010305A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3641—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/50—Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3683—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix subjected to a specific treatment prior to implantation, e.g. decellularising, demineralising, grinding, cellular disruption/non-collagenous protein removal, anti-calcification, crosslinking, supercritical fluid extraction, enzyme treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/005—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Abstract

The invention relates to methods of processing amniotic membrane to generate a substantially 'growth factor free' membrane (GFF-membrane), and to methods of processing GFF-membrane to generate membrane enriched with specific and quantified levels of growth factors or other desirable membrane enriching molecules or compounds (E-membrane). The invention extends to GFF-membrane per se and E-membrane enriched with specific and quantified membrane- enriching compounds per se. The method also includes first and second medical uses of GFF-membrane and E-membrane. The method also extends to clinical uses of the amniotic membrane spongy layer or components thereof.
PCT/GB2006/050209 2005-07-15 2006-07-17 Surgical membrane WO2007010305A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB0800732A GB2441939B (en) 2005-07-15 2006-07-17 Surgical membrane
US11/995,579 US20080193554A1 (en) 2005-07-15 2006-07-17 Surgical Membrane

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0514567.7A GB0514567D0 (en) 2005-07-15 2005-07-15 Surgical membrane
GB0514567.7 2005-07-15

Publications (2)

Publication Number Publication Date
WO2007010305A2 WO2007010305A2 (en) 2007-01-25
WO2007010305A3 true WO2007010305A3 (en) 2008-01-10

Family

ID=34897290

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2006/050209 WO2007010305A2 (en) 2005-07-15 2006-07-17 Surgical membrane

Country Status (3)

Country Link
US (1) US20080193554A1 (en)
GB (2) GB0514567D0 (en)
WO (1) WO2007010305A2 (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9415074B2 (en) 2007-09-07 2016-08-16 Mimedx Group, Inc. Placental tissue grafts
US9433647B2 (en) 2006-08-17 2016-09-06 Mimedx Group, Inc. Placental tissue grafts

Families Citing this family (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007038686A2 (en) * 2005-09-27 2007-04-05 Tissuetech, Inc. Amniotic membrane preparations and purified compositions and methods of use
US8187639B2 (en) 2005-09-27 2012-05-29 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment
CA2722475A1 (en) * 2008-04-25 2009-10-29 Allosource Anti-adhesion barrier wound dressing comprising processed amniotic tissue and method of use
US9358320B2 (en) * 2008-04-25 2016-06-07 Allosource Multi-layer tissue patches
US9480549B2 (en) 2008-04-25 2016-11-01 Allosource Multi-layer tissue patches
EP2421901B1 (en) 2009-04-24 2015-10-28 Tissue Tech, Inc. Compositions containing hc ha complex and methods of use thereof
KR101155638B1 (en) 2009-08-04 2012-07-09 중앙대학교 산학협력단 Novel Preparation Methods for a Decellularized Amniotic Membrane Using a Freeze-Thaw-Centrifuge and Uses Thereof
US20120141595A1 (en) * 2009-08-25 2012-06-07 Tissuetech, Inc. Umbilical cord amniotic membrane products
CA2790333A1 (en) 2010-02-18 2011-08-25 Osiris Therapeutics, Inc. Methods of manufacture of immunocompatible amniotic membrane products
US9352003B1 (en) 2010-05-14 2016-05-31 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US10130736B1 (en) 2010-05-14 2018-11-20 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8883210B1 (en) 2010-05-14 2014-11-11 Musculoskeletal Transplant Foundation Tissue-derived tissuegenic implants, and methods of fabricating and using same
US8840665B2 (en) 2010-06-11 2014-09-23 Liventa Bioscience, Inc. Method of tendon repair with amnion and chorion constructs
US20120010708A1 (en) * 2010-07-08 2012-01-12 AFcell Medical Amnion and chorion replacement cover and uses thereof in surgical repair of muscles
US9433490B2 (en) 2010-12-22 2016-09-06 University Of Florida Research Foundation, Inc. Multilayered implant materials derived from amniotic membrane, methods of making the multilayered implant materials, and method of using multilayered implant materials
EP3311826B1 (en) 2011-02-14 2020-04-29 MiMedx Group, Inc. Micronized placental tissue compositions and methods for making and using the same
US20120237473A1 (en) * 2011-03-14 2012-09-20 University Of Medicine And Dentistry Of New Jersey Compositions And Methods For Cell Based Retinal Therapies
WO2012149486A1 (en) 2011-04-28 2012-11-01 Tissuetech, Inc. Methods of modulating bone remodeling
EP2717888B1 (en) 2011-06-10 2020-09-09 Tissuetech, Inc. Methods of processing fetal support tissues
US9585983B1 (en) 2011-10-12 2017-03-07 BioDlogics, LLC Wound covering and method of preparation
US20130211502A1 (en) * 2012-02-14 2013-08-15 AFcell Medical Method of using amnion allograft in coronary artery bypass grafting
US20130211503A1 (en) * 2012-02-14 2013-08-15 AFcell Medical Method of using amnion allograft in congenital heart disease surgery
US8961617B2 (en) 2012-03-08 2015-02-24 Liventa Bioscience, Inc. Amnion and chorion constructs and uses thereof in abdominal surgery
CA2878163A1 (en) 2012-07-11 2014-01-16 Tissuetech, Inc. Compositions containing hc-ha/ptx3 complexes and methods of use thereof
CA2880157C (en) 2012-08-15 2020-07-21 Mimedx Group, Inc. Reinforced placental tissue grafts and methods of making and using the same
US9943551B2 (en) 2012-08-15 2018-04-17 Mimedx Group, Inc. Tissue grafts composed of micronized placental tissue and methods of making and using the same
US8904664B2 (en) * 2012-08-15 2014-12-09 Mimedx Group, Inc. Dehydration device and methods for drying biological materials
US9180145B2 (en) 2012-10-12 2015-11-10 Mimedx Group, Inc. Compositions and methods for recruiting and localizing stem cells
JP6545102B2 (en) 2013-01-18 2019-07-17 ミメディクス グループ インコーポレイテッド How to treat a cardiac condition
US10206977B1 (en) 2013-01-18 2019-02-19 Mimedx Group, Inc. Isolated placental stem cell recruiting factors
US10905800B1 (en) 2013-01-29 2021-02-02 BioDlogics, LLC Ocular covering and method of use
US9498327B1 (en) 2013-03-05 2016-11-22 Biodlogics Llc Repair of tympanic membrane using human birth tissue material
US9789138B1 (en) 2013-03-06 2017-10-17 BioDlogics, LLC Neural repair construct and method of use
US9770472B1 (en) 2013-03-08 2017-09-26 Brahm Holdings, Llc Organ jacket and methods of use
US9855301B1 (en) 2013-03-13 2018-01-02 Biodlogics Llc Human birth tissue laminate and methods of use
US10029030B2 (en) 2013-03-15 2018-07-24 Mimedx Group, Inc. Molded placental tissue compositions and methods of making and using the same
US9795638B1 (en) 2013-03-16 2017-10-24 BioDlogics, LLC Cardiothoracic construct and methods of use
GB201309963D0 (en) 2013-06-04 2013-07-17 Univ Nottingham Amniotic membrane
EP3094336A4 (en) 2014-01-17 2018-02-14 MIMEDX Group Inc. Method for inducing angiogenesis
EP3185918B1 (en) 2014-08-28 2021-08-18 MiMedx Group, Inc. Collagen reinforced tissue grafts
US20160095307A1 (en) * 2014-10-07 2016-04-07 NuTech Medical, Inc. Method and composition for hypothermic storage of placental tissue
US10265438B1 (en) * 2014-11-03 2019-04-23 BioDlogics, LLC Methods and compositions for the repair and replacement of connective tissue
US10765705B2 (en) 2014-11-24 2020-09-08 Prime Merger Sub, Llc Visco-supplement compositions, and methods of use thereof
WO2016138025A2 (en) 2015-02-23 2016-09-01 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
WO2016187555A1 (en) 2015-05-20 2016-11-24 Tissuetech, Inc. Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells
US10531957B2 (en) 2015-05-21 2020-01-14 Musculoskeletal Transplant Foundation Modified demineralized cortical bone fibers
WO2017112934A1 (en) * 2015-12-23 2017-06-29 Lifenet Health Decellularized placental membrane and methods of preparing and use thereof
US10583219B1 (en) * 2015-12-29 2020-03-10 Brahm Holdings, Llc Multilayer bioabsorbable construct and methods of use
TW201733600A (en) 2016-01-29 2017-10-01 帝聖工業公司 Fetal support tissue products and methods of use
RU2671515C1 (en) * 2018-04-13 2018-11-01 Федеральное государственное бюджетное учреждение "Московский научно-исследовательский институт глазных болезней имени Гельмгольца" Министерства здравоохранения Российской Федерации Method of keratoprosthesis of thinned burn leukoma
CN111330081B (en) * 2020-05-09 2022-03-29 山东省眼科研究所 Preparation method of medicine-carrying amniotic membrane and influence of medicine-carrying amniotic membrane on corneal epithelium repair
US11944718B1 (en) * 2022-05-11 2024-04-02 Healthtech Solutions, Inc. Compositions and manufacture of allograft tissue

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2110531A (en) * 1981-11-05 1983-06-22 East Grinstead Research Trust Wound healing composition prepared from amnion
EP0669138A2 (en) * 1994-02-24 1995-08-30 Research Development Foundation Amniotic membrane graft or wrap to prevent adhesions or bleeding of internal organs
US6152142A (en) * 1997-02-28 2000-11-28 Tseng; Scheffer C. G. Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
US20030187515A1 (en) * 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
US20030235580A1 (en) * 2002-06-24 2003-12-25 Fen Zhang Amniotic membrane mediated delivery of bioactive molecules
US20040057938A1 (en) * 2002-09-18 2004-03-25 Emiliano Ghinelli Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin
WO2005075002A1 (en) * 2004-02-04 2005-08-18 National Institute For Materials Science Medical material and process for producing the same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09122225A (en) * 1995-10-31 1997-05-13 Bio Eng Lab:Kk Raw membrane material for medical material and manufacture thereof
US20060228339A1 (en) * 2003-06-16 2006-10-12 Zheng-Pin Wang Methods of preparing transplantable product for treatment of skin defects
CN1884495A (en) * 2005-06-24 2006-12-27 和泓生物技术（上海）有限公司 Human amnion cell capable of expressing extraneous gene and its preparation method and uses

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2110531A (en) * 1981-11-05 1983-06-22 East Grinstead Research Trust Wound healing composition prepared from amnion
EP0669138A2 (en) * 1994-02-24 1995-08-30 Research Development Foundation Amniotic membrane graft or wrap to prevent adhesions or bleeding of internal organs
US6152142A (en) * 1997-02-28 2000-11-28 Tseng; Scheffer C. G. Grafts made from amniotic membrane; methods of separating, preserving, and using such grafts in surgeries
US20030187515A1 (en) * 2002-03-26 2003-10-02 Hariri Robert J. Collagen biofabric and methods of preparing and using the collagen biofabric
US20030235580A1 (en) * 2002-06-24 2003-12-25 Fen Zhang Amniotic membrane mediated delivery of bioactive molecules
US20040057938A1 (en) * 2002-09-18 2004-03-25 Emiliano Ghinelli Use of a human amniotic membrane composition for prophylaxis and treatment of diseases and conditions of the eye and skin
WO2005075002A1 (en) * 2004-02-04 2005-08-18 National Institute For Materials Science Medical material and process for producing the same

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
AZUARA-BLANCO A ET AL: "AMNIOTIC MEMBRANE TRANSPLANTATION FOR OCULAR SURFACE RECONSTRUCTION", BRITISH JOURNAL OF OPHTHALMOLOGY, LONDON, GB, vol. 83, no. 4, April 1999 (1999-04-01), pages 399 - 402, XP001149427, ISSN: 0007-1161 *
DUA, H.S. ET AL.: "DIAGNOSTIC AND SURGICAL TECHNIQUE", SURVEY OF OPHTHALMOLOGY, vol. 49, no. 1, 2004, pages 51 - 77, XP002444172 *
HOPKINSON A. ET AL., INVESTIGATIVE OPHTHALMOLOGY AND VISUAL SCIENCE, vol. 47, 2006, pages 4316 - 4322, XP002444173 *
TSENG, S.C. ET AL.: "SUPRESSION OF TRANSFORMING GROWTH FACTOR-BETA ISOFORMS, TGF-BETA RECEPTOR TYPE II, AND MYOFIBROBLAST DIFFERENTIATION IN CULTURED HUMAN CORNEAL AND LIMBAL FIBROBLASTS BY AMNIOTIC MEMBRANE MATRIX.", JOURNAL OF CELLULAR PHYSIOLOGY, vol. 179, 1999, pages 325 - 335, XP002444171 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9433647B2 (en) 2006-08-17 2016-09-06 Mimedx Group, Inc. Placental tissue grafts
US9415074B2 (en) 2007-09-07 2016-08-16 Mimedx Group, Inc. Placental tissue grafts

Also Published As

Publication number Publication date
GB2441939A (en) 2008-03-19
US20080193554A1 (en) 2008-08-14
GB2441939B (en) 2011-03-16
WO2007010305A2 (en) 2007-01-25
GB0800732D0 (en) 2008-02-20
GB0514567D0 (en) 2005-08-24

Similar Documents

Publication Publication Date Title
WO2007010305A3 (en) Surgical membrane
ATE493492T1 (en) METHOD AND SYSTEM FOR PRODUCING STEM CELLS FROM ADIBLE TISSUE
WO2007067280A3 (en) Very small embryonic-like (vsel) stem cells and methods of isolating and using the same
WO2007002572A3 (en) Nattokinase for reducing whole blood viscosity
WO2006019434A3 (en) Composite outsole
WO2009059032A3 (en) Uses and isolation of very small embryonic-like (vsel) stem cells
WO2006020773A3 (en) Methods for preparing freeze-dried platelets, compositions comprising freeze-dried platelets, and methods of use
EP2722387A3 (en) Definitive endoderm
WO2004037861A3 (en) Neutralizing antibodies against gdf-8 and uses therefor
WO2005099680A3 (en) Use of treprostinil to treat neuropathic diabetic foot ulcers
WO2007030743A3 (en) Cochlear implants containing biological cells and uses thereof
WO2005106090A3 (en) Preform produced by electrospinning, method for producting the same and use of such a preform
WO2003027248A8 (en) Antibody inhibitors of gdf-8 and uses thereof
WO2006093857A3 (en) Method of providing readily available cellular material derived from peripheral blood and a composition thereof
WO2008045021A3 (en) Blood compatible nanomaterials and methods of making and using the same
WO2008027420A3 (en) Implantable devices for producing insulin
WO2006081435A3 (en) Method of providing readily available cellular material derived from cord blood, and a composition thereof
BRPI0416898A (en) tangential flow filtering devices and methods for stem cell enrichment
WO2006093860A3 (en) Method and composition for repairing heart tissue
BRPI0412715A (en) oligodendrocyte precursor cells and methods of obtaining and culturing them
WO2005042727A3 (en) Methods of organ regeneration
WO2006041409A8 (en) Medical solution, method for producing and use thereof
WO2006019978A3 (en) Compositions and methods for diagnosis and treatment of epilepsy
WO2007064304A8 (en) Biocompatible composition and uses thereof
WO2004069194A3 (en) Use of the oxidoreductase ncb50r for diagnosings and treating diabetes

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 11995579

Country of ref document: US

ENP Entry into the national phase

Ref document number: 0800732

Country of ref document: GB

Kind code of ref document: A

Free format text: PCT FILING DATE = 20060717

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 800732

Country of ref document: GB

Ref document number: 0800732.0

Country of ref document: GB

WWW Wipo information: withdrawn in national office

Country of ref document: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06765358

Country of ref document: EP

Kind code of ref document: A2